Harvard Drug Group, LLC – Trademark Portfolio
Entity Type: 16
Harvard Drug Group, LLC holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 9 trademarks are registered. Notable registered marks include LETCO, MAJOR, ROBAFEN, CERTAVITE, and EXPERTMED. The owner is based in Dublin, OH.
7000 Cardinal Place
Dublin, OH 43017
Showing of trademarks Trademarks
Trademark Classifications
Harvard Drug Group, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Harvard Drug Group, LLC have?
Harvard Drug Group, LLC has 19 U.S. trademarks filed with the USPTO. Of these, 9 registered, 5 abandoned, 5 cancelled.
What trademark classes does Harvard Drug Group, LLC file in?
Harvard Drug Group, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Harvard Drug Group, LLC's most well-known trademarks?
Harvard Drug Group, LLC's registered trademark portfolio includes well-known marks such as LETCO, MAJOR, ROBAFEN, CERTAVITE, and EXPERTMED. These are among 9 currently registered trademarks in the portfolio.
What is Harvard Drug Group, LLC's trademark registration success rate?
Harvard Drug Group, LLC has a 47% trademark registration rate, with 9 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.